Showing results (31-40 of 586) with videos related to
Sort By:
Pageof 59
Antimicrobial Agents and Chemotherapy|October 3, 1998
PMX-622 (polymyxin B-dextran 70) does not alter in vitro activities of 11 antimicrobial agentsP C Fuchs, A L Barry, S D BrownDiagnostic Microbiology and Infectious Disease|February 6, 1999
Multicenter survey of the in vitro activity of four expanded-spectrum beta-lactams against consecutive contemporary clinical isolatesP C Fuchs, A L Barry, S D BrownAntimicrobial Agents and Chemotherapy|December 3, 1999
In vitro activities of SCH27899 alone and in combination with 17 other antimicrobial agentsP C Fuchs, A L Barry, S D BrownThe Journal of Antimicrobial Chemotherapy|October 3, 2001
Evaluation of daptomycin susceptibility testing by Etest and the effect of different batches of mediaP C Fuchs, A L Barry, S D BrownAntimicrobial Agents and Chemotherapy|May 17, 2001
In vitro activities of three nonfluorinated quinolones against representative bacterial isolatesA L Barry, P C Fuchs, S D BrownAntimicrobial Agents and Chemotherapy|September 15, 2001
In vitro activity of the ketolide ABT-773A L Barry, P C Fuchs, S D BrownDiagnostic Microbiology and Infectious Disease|September 1, 1996
Tentative interpretive criteria for testing the susceptibility of Streptococcus pneumoniae to eight fluoroquinolonesP C Fuchs, A L Barry, S D BrownEuropean Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 24, 1997
In vitro activity of the new ketolide HMR 3004 compared to an azalide and macrolides against Streptococcus pneumoniae and Haemophilus influenzaeA L Barry, P C Fuchs, S D BrownAntimicrobial Agents and Chemotherapy|May 21, 1998
In vitro activities of clinafloxacin against contemporary clinical bacterial isolates from 10 North American centersP C Fuchs, A L Barry, S D BrownEuropean Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1996
In vitro activity and selection of disk content for disk diffusion susceptibility tests with trovafloxacinP C Fuchs, A L Barry, S D Brown, et al.Pageof 59